Note: A hyperlink is attached in each headlines for further reading of the original news.
Table of Contents:
1. United Kingdom News 2. Malaysia News
1. UNITED KINGDOM NEWS
Date: 19th June 2020
Source: The National
Monthly Visitors: 263,910
Summary:
Professor Linda Bauld (University of Edinburgh) stated that UK ministers failed to explain that their decision only applies to England.
There was lack of transparency from the UK government in the early days of the pandemic.
Bauld elaborated that the SAGE advisory group is almost devoid of people with "on the ground public health experience."
Survey shows that trust in Government messaging is higher in Scotland than in England.
Date: 17th June 2020
Source: The Guardian
Monthly Visitors: 92,205,690
Summary:
The National Institute for Health And Care Excellence (NICE) are reviewing the potential of Vitamin D to reduce risk of Coronavirus, with support from Public Health England (PHE).
A professor of respiratory infection and immunity observed that Vitamin D could help the body handle viral respiratory infections, boosts the cells' ability to kill viruses, and dampen harmful inflammations (which is one of the biggest problems of COVID-19).
Date: 17th June 2020
Source: Health Europa
Monthly Visitors: 222,570
Summary:
Sapphire Medical Clinics launched its Medical Cannabis Registry initiative to expand evidence base for medical cannabis in the UK, and decrease cost of access for patients.
The launch will collect and analyse the patient's clinical information who are taking medical cannabis treatments for all recognised eligible conditions.
Patients on the scheme will have greater insights on how the treatment affects them via the Real World Evidence Platform.
2. MALAYSIA NEWS
Date: 17th June 2020
Source: New Straits Times
Monthly Visitors: 1,634,940
Summary:
Several associations want to meet Malaysian PM on the matter of implementing the new shift system at government clinics.
An online survey showed that 92% of 9,320 respondents objected to the new system.
Date: 17th June 2020
Source: The Star
Monthly Visitors: 3,465,270
Summary:
There is a controversy about using hydroxychloroquine on patients.
The use of the drug became controversial as a result of reports of death due to reported arrhythmia (irregular heart rate) and cardiac arrest among patients it was given to.
Malaysia found a way to test hydroxychloroquine on patients with respiratory disease without harming them.
A reported was compiled on this matter called: "The Malaysian Response to Covid-19: Building Preparedness for 'Surge Capacity', Testing Efficiency, and Containment'.
Chinese expertise found lower doses of the drug is effective.
Hospital Sungai Buloh's Consultant Infectious Disease Physician stated that from Chinese experience, using lower dosage of the drug works.
Date: 17th June 2020
Source: The Edge Markets
Monthly Visitors: 879,900
Summary:
Duopharma Biotech will move forward to expand its consumer healthcare (CHC) product portfolio and diversify into high-value biologicals and niche products.
The CHC business has contributed greatly to the Duopharma's performance.
Duopharma's Flavettes Effervescent Vitamin C is the bestseller among immunity-boosting products.
Duopharma is the first pharmaceutical company to commercialise erythropoietin branded as Erysaa
Duopharma's breast-cancer treatment drug will be launched soon.